FDA approves first drug offering a 'functional cure' for chronic hepatitis B
The approval marks a new treatment class for chronic hepatitis B, a virus affecting hundreds of millions worldwide.
Read at ScienceAlert โFull coverage ยท 15 outlets
- ScienceAlert ยท lead
- Pharmacy Practice NewsFDA Approves Hibsago for Chronic HBV Infection
- ReutersUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
- The American Journal of Managed CareBepirovirsen Approval Offers New Option for Chronic HBV Treatment
- Contagion LiveFDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B
- BioPharma DiveGSK, Ionis win US approval for first-of-its-kind hepatitis B drug
- Hep Treatment NewsFDA Approves New Type of Treatment for Hepatitis B
- Endpoints NewsGSK gets FDA approval for hepatitis B drug that offers functional cure
- MedCity NewsGSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure
- The Pharma LetterFDA approves first-of-its-kind chronic hepatitis B treatment
- New AtlasBreakthrough hepatitis B drug offers 'functional cure' for first time
- Pharmaceutical TechnologyFDA approves GSKโs Hibsago as first functional cure for hepatitis B
- Drug Discovery NewsFDA approves GSK's functional cure for hepatitis B
- TrialSite NewsFDA Approves Hepatitis B Breakthrough: 19% Achieve Functional Cure, but Serious Safety Risks Complicate the Promise
- MSNBreakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B